During the past decade, Spitalul Judetean de Urgenta Braila conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Judetean de Urgenta Braila" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Judetean de Urgenta Braila" are "Cardiovascular Disease" (2 trials), "Myocardial Infarction" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Spitalul Judetean de Urgenta Braila" in a lesser frequency.

Most popular intervention types in "Spitalul Judetean de Urgenta Braila" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Empagliflozin" (1 trials) and "Talactoferrin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Judetean de Urgenta Braila" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Spitalul Judetean de Urgenta Braila". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Spitalul Judetean de Urgenta Braila, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Judetean de Urgenta Braila, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".